Back to search

Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor‐platelet interaction and response to treatment

Data up to Jan 2025

Published1988
Citations54
References14

Total Citations Per Year

Abstract

References (14)

Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects

1986 • 206 citations

Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies

1984 • 158 citations

Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome

1986 • 112 citations

Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies

1986 • 93 citations

Acquired von Willebrand's Disease

1978 • 85 citations

Pathogenesis of antibody‐induced acquired von willebrand syndrome

1980 • 42 citations

Investigation of a case of subtype IIC von Willebrand disease: Characterization of the variability of this subtype

1986 • 31 citations

Profound alterations of the multimeric structure of von Willebrand factor in a patient with malignant lymphoma

1985 • 28 citations

Improved Characterization of Plasma von Willebrand Factor Heterogeneity when Using 2.5% Agarose Gel Electrophoresis

1986 • 25 citations

Acquired Haemophilia: Functional Study of Antibodies to Factor VIII

1981 • 21 citations

Demonstration of abnormal factor VIII multimers in acquired von Willebrand's disease associated with a circulating inhibitor

1987 • 20 citations

Effect of Carbohydrate Modifications of Factor VIII/ von Willebrand Factor on Binding to Platelets

1985 • 16 citations

Hemophilic patients with an inhibitor to factor VIII treated with high dose factor VIII concentrate. Results of a collaborative study for the evaluation of factor VIII inhibitor titer, recovery and half life of infused factor VIII.

1986 • 8 citations

Étude d'un concentré thérapeutique de facteur VIII/vWf préparé en circuit clos

1982 • 5 citations

Cited By (0)

Loading...